Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blanco

Showing results (651-660 of 816) with videos related to

Pageof 82
Sort By:
Archives of Andrology|August 2, 2003
Asthenozoospermia: analysis of a large populationS M Curi, J I Ariagno, P H Chenlo, et al.
Clinical and Vaccine Immunology : CVI|September 19, 2008
Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assaysTatiane R Oliveira, Mariana T Longhi, Zenaide M de Morais, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidusD R Repaske, M L Summar, M R Krishnamani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2013
HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytesJuan A Moreno, Cristina Sastre, Julio Madrigal-Matute, et al.
Kidney International. Supplement|December 13, 2005
Proteomic approach in the search of new cardiovascular biomarkersJulio Gallego-Delgado, Alberto Lazaro, Julio I Osende, et al.
Revista De Neurologia|August 3, 2006
[Topiramate in comorbid disorders: epilepsy and migraine]R Dorado, J M Gómez-Arguelles, A Herrera, et al.
Atherosclerosis|May 29, 2009
The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosisJuan A Moreno, Begoña Muñoz-García, Jose L Martín-Ventura, et al.
Kidney International. Supplement|November 27, 2008
Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFASTLuis M Blanco-Colio, Jose L Martín-Ventura, Eduardo de Teresa, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
NVC-422 topical gel for the treatment of impetigoSusan M Iovino, Kenneth D Krantz, Daisy M Blanco, et al.
Cureus|February 1, 2024
Ten Steps to Conduct a Systematic ReviewErnesto Calderon Martinez, Jose R Flores Valdés, Jaqueline L Castillo, et al.
Pageof 82

Showing results (651-660 of 816) with videos related to

Sort By:
Pageof 82
Archives of Andrology|August 2, 2003
Asthenozoospermia: analysis of a large populationS M Curi, J I Ariagno, P H Chenlo, et al.
Clinical and Vaccine Immunology : CVI|September 19, 2008
Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assaysTatiane R Oliveira, Mariana T Longhi, Zenaide M de Morais, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidusD R Repaske, M L Summar, M R Krishnamani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2013
HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytesJuan A Moreno, Cristina Sastre, Julio Madrigal-Matute, et al.
Kidney International. Supplement|December 13, 2005
Proteomic approach in the search of new cardiovascular biomarkersJulio Gallego-Delgado, Alberto Lazaro, Julio I Osende, et al.
Revista De Neurologia|August 3, 2006
[Topiramate in comorbid disorders: epilepsy and migraine]R Dorado, J M Gómez-Arguelles, A Herrera, et al.
Atherosclerosis|May 29, 2009
The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosisJuan A Moreno, Begoña Muñoz-García, Jose L Martín-Ventura, et al.
Kidney International. Supplement|November 27, 2008
Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFASTLuis M Blanco-Colio, Jose L Martín-Ventura, Eduardo de Teresa, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
NVC-422 topical gel for the treatment of impetigoSusan M Iovino, Kenneth D Krantz, Daisy M Blanco, et al.
Cureus|February 1, 2024
Ten Steps to Conduct a Systematic ReviewErnesto Calderon Martinez, Jose R Flores Valdés, Jaqueline L Castillo, et al.
Pageof 82